Altered neural activation during prepotent response inhibition in breast cancer survivors treated with chemotherapy: an fMRI study.

Brain Imaging Behav. 2015 Oct 21;

Authors: Kam JW, Boyd LA, Hsu CL, Liu-Ambrose T, Handy TC, Lim HJ, Hayden S, Campbell KL

Abstract
While impairments in executive functions have been reported in breast cancer survivors (BCS) who have undergone adjuvant chemotherapy, only a limited number of functional neuroimaging studies have associated alterations in cerebral activity with executive functions deficits in BCS. Using fMRI, the current study assessed the neural basis underlying a specific facet of executive function, namely prepotent response inhibition. 12 BCS who self-reported cognitive problems up to 3 years following cancer treatment and 12 female healthy comparisons (HC) performed the Stroop task. We compared their neural activation between the incongruent and neutral experimental conditions. Relative to the HC group, BCS showed lower blood-oxygen level dependent signal in several frontal regions, including the anterior cingulate cortex, a region critical for response inhibition. Our data indicates reduced neural activation in BCS during a prepotent response inhibition task, providing support for the prevailing notion of neural alterations observed in BCS treated with chemotherapy.

PMID: 26489975 [PubMed - as supplied by publisher]